Viewing Study NCT01256151


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-26 @ 4:31 PM
Study NCT ID: NCT01256151
Status: COMPLETED
Last Update Posted: 2021-01-28
First Post: 2010-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anxiety Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioequivalence View
None sublingual View
None alprazolam View
None pharmacokinetics View